Skip to main content
Premium Trial:

Request an Annual Quote

AlphaGene Gets Patent for Genomic Database Agents



OBURN, Mass.--AlphaGene, an integrated genomics company, said it has received a patent for agents used in genomic databases from the US Patent and Trademark Office. The patent covers the use of agents that implement continuous, selective database updates to proceed asynchronously with respect to the addition of new data into the database. These agents keep large and dynamic databases well annotated and up-to-date, while allowing users to keep long-running searches alive for entries meeting certain annotation criteria.

Changes in methods of annotation or amount of data in the databases do not limit users who continue using and researching the databases. The patented agents "sense" the status of the database entries while processing and updating the data and update only the pertinent criteria and annotations in the database. The remaining entries are left untouched.

Filed under

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.